Related Experiment Video
Updated: Jun 4, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Current state of ventricular assist devices
Marco Caccamo1, Peter Eckman, Ranjit John
1Department of Medicine, Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, MN, USA.
Current Heart Failure Reports
|February 22, 2011
Summary
Continuous-flow (CF) left ventricular assist devices (LVADs) offer improved outcomes for end-stage heart failure patients compared to older pulsatile models. This review covers their clinical results, physiological effects, and unique management challenges.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Left ventricular assist device (LVAD) support is a key treatment for end-stage heart failure.
- LVADs are used for bridge-to-transplant and destination therapy (DT).
- Historically, pulsatile LVADs were standard; newer continuous-flow (CF) pumps now dominate.
Purpose of the Study:
- To review the current status of LVADs, focusing on continuous-flow (CF) pumps.
- To discuss clinical outcomes, physiological effects, and management challenges associated with CF LVADs.
Main Methods:
- Review of current literature on continuous-flow left ventricular assist devices.
- Analysis of clinical outcomes, physiological impacts, and management issues.
Main Results:
- Continuous-flow LVADs demonstrate superior outcomes and durability compared to pulsatile devices.
- CF pumps have introduced novel management challenges and complications.
- Understanding these challenges is crucial for effective patient management.
Conclusions:
- Continuous-flow LVADs represent a significant advancement in heart failure treatment.
- Effective management of CF LVADs requires addressing their unique complications and physiological effects.
- Further research into optimizing CF LVAD therapy is warranted.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:23Mechanical Ventilation II: Invasive Ventilation
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
01:29Mechanical Ventilation I: Indication and Settings
Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:23Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Noninvasive Positive-Pressure Ventilation (NIPPV)